Can 1st Quarter Losers Barclays PLC (-32%), Shire PLC (-16%) & Ophir Energy Plc (-22%) Bounce Back?

Royston Wild runs the rule over London laggards Barclays PLC (LON: BARC), Shire PLC (LON: SHP) and Ophir Energy Plc (LON: OPHR).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am taking a look at three heavy first-quarter fallers.

Drugs darling

Medicines play Shire (LSE: SHP) emerged from the first quarter as one of the FTSE 100’s biggest fallers in often-choppy trading conditions.  Investor confidence has shaken in recent months, as concerns over the strategic advantages of Shire’s $32bn takeover of biopharmaceuticals specialist Baxalta have weighed.

Still, it could be argued that Shire’s share price under-performance since the start of 2016 leave the firm dealing at irresistible prices at present. The City expects Shire to enjoy an 11% earnings bounce in 2016, resulting in an excellent P/E ratio of 13.2 times.

I reckon this is decent value given the Shire’s improving product pipeline — the pharma play currently has 14 products in or around the Phase III testing phase — not to mention the positive impact of rising global healthcare investment on future earnings.

Still sinking

Shares in oil explorer Ophir Energy (LSE: OPHR) have failed to reflect recent Brent crude strength, the benchmark having climbed back above the $40 per barrel milestone in March.

Market sentiment towards the broader oil segment remains fragile, as further swathes of disappointing Chinese economic data, combined with fading hopes for a co-ordinated supply cut by major global producers, have weighed.

Ophir Energy announced last month that it had incurred a $376m pre-tax operating loss in 2015 as a tanking oil price prompted massive impairments. On top of this, the company’s capex-intensive operations also caused net cash to slump to $355m as of December, collapsing from $1.17bn a year earlier.

The City expects Ophir Energy to keep pumping in losses until 2018 at the earliest. With the supply imbalance washing over the oil market steadily worsening, I believe Ophir Energy can expect further share price weakness looking ahead.

A banking beauty?

The steady share price downtrend that kicked off last summer at Barclays (LSE: BARC) is showing no signs of letting up. The stock shed almost a third of its value during the first quarter alone, and remains on the cusp of hitting fresh multi-year troughs.

The entire banking industry has found itself on the rocks in recent months — indeed, Barclays, RBS and HSBC were three of the FTSE 100’s top five fallers during quarter one — as the flailing global economy has again raised fears over the strength of the financial sector. Meanwhile, concerns over the consequences of a ‘leave’ vote in June’s referendum has done the sector no favours, either.

The age-old problem of misconduct-related penalties has also remained a millstone around the sector’s neck, with Barclays itself setting aside another £1.45bn for PPI-related claims during the final quarter of 2015 alone.

As a consequence, Barclays has shocked investors by electing to slash the dividend through to the close of 2017, more than halving it to 3p per share from 6.5p in recent years. But this may not be the end of the matter, as the number of PPI claimants is expected to shoot higher ahead of a possible 2018 deadline.

Fears over the future direction of the bank under new CEO Jes Staley have also weighed on the bank, with Barclays having announced the sale of its African banking assets, massive changes across its Investment Bank, and forthcoming measures to split the bank into two separate divisions in recent weeks.

The City expects Barclays to enjoy a 1% earnings advance in 2016, resulting in a P/E rating of just 10.5 times. While this suggests the bank’s upheavals are currently priced in at current levels, I believe there is enough mud in the water to push the bank’s stock still lower in the months ahead.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Barclays. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Google office headquarters
Investing Articles

1 reason I like buying S&P 500 shares – and 1 reason I don’t

Will this investor try to improve his potential returns by focusing more on S&P 500 shares instead of British ones?…

Read more »

Young woman holding up three fingers
Investing Articles

3 SIPP mistakes to avoid

Our writer explains a trio of potentially costly errors he tries to avoid making when investing his SIPP, on an…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Here’s how (and why) I’d start buying shares with £25 a week

Our writer uses his investment experience and current approach to explain how he would start buying shares on a limited…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s my 5-step approach to earning passive income of £500 a month

Christopher Ruane explains the handful of steps he uses to target hundreds of pounds in passive income each month.

Read more »

Investing Articles

2 UK shares I’ve been buying this week

From a value perspective, UK shares look attractive. But two in particular have been attracting Stephen Wright’s attention over the…

Read more »

Investing Articles

A lifelong second income for just £10 a week? Here’s how!

With a simple, structured approach to buying blue-chip dividend shares at attractive prices, our writer's building a second income for…

Read more »

Investing Articles

Here’s how I’d use a £20k Stocks and Shares ISA to help build generational wealth

Discover how our writer would aim to turn a £20k Stocks and Shares ISA into a sizeable nest egg by…

Read more »